1. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study;Verhelst;Acta Endocrinol (Copenh),1991
2. Quinagolide—a valuable treatment option for hyperprolactinaemia;Barlier;Eur J Endocrinol,2006
3. CV 205-502: safety, tolerance to, and efficacy of increasing doses in patients with Parkinson's disease in a double-blind, placebo crossover study;Olanow;Clin Neuropharmacol,1989
4. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis;Baumgarten;Hum Fertil (Camb),2013
5. Lactation inhibition by the dopamine agonist CV 205-502;van der Heijden;Br J Obstet Gynaecol,1991